Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018
|
|||||
|
|
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal  Comments are closed  Finance  biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, life sciences, merger, pharmaceuticals, U.K., university 
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, equity, FDA, genomics, investment, life sciences, merger, pharmaceuticals, university 
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, equity, genomics, investment, life sciences, merger, pharmaceuticals 
Our friends at CB Insights put together a chart showing Amazon’s largest acquisitions in dollar value, this weekend’s infographic. . . . → Read More: Infographic – Amazon’s Largest Acquisitions A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal Comments are closed Finance biomedical, biotechnology, clinical trials, equity, Europe, FDA, genomics, investment, life sciences, merger, pharmaceuticals The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal Comments are closed Finance biomedical, cancer, engineering, equity, FDA, genomics, investment, life sciences, medical device, merger, software Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal Comments are closed Finance biomedical, biotechnology, equity, Europe, investment, life sciences, merger, nanotechnology, pharmaceuticals The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, licensing, life sciences, merger, pharmaceuticals, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||